PSI-7977 (GS-7977)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PSI-7977 (GS-7977), covering 2014-10-22 to 2014-10-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study of TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients [Phase 2]